RxDoctor Payments DataLook up a doctor →

Jared Weiss, MD

Hematology & Oncology · Chapel Hill, NCNPI 1376577130

Payments from drug & device makers

$7,265,600in general payments, 2019–2025

Across 445 payments — averaging $16,327 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$3.3M
  • Merck$913K
  • Mirati Therapeutics, Inc.$796K
  • AstraZeneca$744K
  • Astrazeneca UK Limited$396K
  • Amgen$364K
  • plus $705K from 34 others
$24,366in research payments, 2019–2025

Across 7 payments — averaging $3480.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$10K
  • EMD Serono, Inc.$5K
  • Pfizer$5K
  • Bristol Myers Squibb$3K
  • AbbVie$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,265,600 in reported general payments places this provider in the 95th percentile of 358 hematology & oncology providers in North Carolina.

See all hematology & oncology providers in North Carolina

Medicare billing

Part B allowed, 2024
$52,342
Medicare patients
105
Services billed
664

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Chapel Hill

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →